Mark Poritz
Director Técnico/Científico/I+D en CO-DIAGNOSTICS, INC. .
Cargos activos de Mark Poritz
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CO-DIAGNOSTICS, INC. | Director Técnico/Científico/I+D | 01/11/2022 | - |
Historial de carrera de Mark Poritz
Antiguos cargos conocidos de Mark Poritz.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Idaho Molecular, Inc.
 Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Director Técnico/Científico/I+D | - | - |
Formación de Mark Poritz.
| University of California | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CO-DIAGNOSTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Poritz
- Experiencia
